HIV and Stage 3 (AIDS) Classifications Data through December 2020 Provided for the Ryan White HIV/AIDS Program, for Fiscal Year 2022: Tables

Table 1. Reported stage 3 (AIDS) classifications and persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS), by area of residence, 2016–2020, and as of December 2020—eligible metropolitan areas and transitional grant areas for the Ryan White HIV/AIDS Program
Reported stage 3 (AIDS) classifications 2016–2020 Persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS) (as of December 2020)
Area of residence No. No.
Eligible metropolitan areas (EMAs)
Atlanta-Sandy Springs-Marietta, Georgia 4,280 17,715
Baltimore, Maryland 1,435 9,591
Boston-Brockton-Nashua, Massachusetts-New Hampshire 1,336 10,003
Chicago, Illinois 2,686 15,884
Dallas, Texas 2,273 11,497
Detroit, Michigan 1,128 5,703
Fort Lauderdale, Florida 1,488 9,457
Houston, Texas 2,775 15,184
Los Angeles-Long Beach, California 3,689 28,279
Miami, Florida 2,258 14,675
Nassau-Suffolk, New York 560 3,542
New Haven-Bridgeport-Danbury-Waterbury, Connecticut 350 3,825
New Orleans, Louisiana 757 4,602
New York, New York 5,632 59,818
Newark, New Jersey 933 6,894
Orlando, Florida 1,338 6,253
Philadelphia, Pennsylvania-New Jersey 1,636 13,638
Phoenix-Mesa, Arizona 1,101 5,370
San Diego, California 832 7,410
San Francisco, California 708 10,357
San Juan-Bayamon, Puerto Rico 772 6,069
Tampa-St. Petersburg-Clearwater, Florida 1,345 6,634
Washington, DC-Maryland-Virginia-West Virginia 2,574 19,201
West Palm Beach-Boca Raton, Florida 685 4,913
Transitional grant areas (TGAs)
Austin-San Marcos, Texas 473 3,247
Baton Rouge, Louisiana 545 2,713
Bergen-Passaic, New Jersey 297 2,384
Charlotte-Gastonia-Concord, North Carolina-South Carolina 617 3,086
Cleveland-Lorain-Elyria, Ohio 611 2,689
Columbus, Ohio 597 2,568
Denver, Colorado 639 4,101
Fort Worth-Arlington, Texas 623 2,912
Hartford, Connecticut 230 2,177
Indianapolis, Indiana 521 2,719
Jacksonville, Florida 782 3,894
Jersey City, New Jersey 372 2,869
Kansas City, Missouri-Kansas 413 2,871
Las Vegas, Nevada-Arizona 938 3,839
Memphis, Tennessee-Mississippi-Arkansas 838 3,770
Middlesex-Somerset-Hunterdon, New Jersey 241 1,660
Minneapolis-St. Paul, Minnesota-Wisconsin 575 3,319
Nashville-Davidson-Murfreesboro, Tennessee 422 2,606
Norfolk-Virginia Beach-Newport News, Virginia 641 2,841
Oakland, California 544 5,060
Orange County, California 588 4,102
Portland-Vancouver, Oregon-Washington 353 2,768
Riverside-San Bernardino, California 1,092 5,459
Sacramento, California 427 2,148
St. Louis, Missouri-Illinois 624 3,683
San Antonio, Texas 681 3,429
San Jose, California 268 2,355
Seattle-Bellevue-Everett, Washington 575 4,563

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Commentary for definition of eligible metropolitan areas (EMAs) and transitional grant areas (TGAs).

Table 2. Reported stage 3 (AIDS) classifications and persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS), by area of residence, 2016–2020, and as of December 2020—emerging communities for the Ryan White HIV/AIDS Program
Reported stage 3 (AIDS) classifications 2016–2020 Persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS) (as of December 2020)
Emerging communities (ECs) No. No.
Albany-Schenectady-Troy, New York 167 1,100
Augusta-Richmond County, Georgia-South Carolina 345 1,222
Bakersfield, California 252 1,253
Birmingham-Hoover, Alabama 421 1,675
Buffalo-Niagara Falls, New York 189 1,202
Charleston-North Charleston, South Carolina 250 1,371
Cincinnati-Middletown, Ohio-Kentucky-Indiana 566 2,207
Columbia, South Carolina 423 2,476
Jackson, Mississippi 374 1,752
Lakeland, Florida 260 1,202
Louisville, Kentucky-Indiana 385 1,756
Milwaukee-Waukesha-West Allis, Wisconsin 270 1,606
North Port-Bradenton-Sarasota, Florida* 187 1,059
Oklahoma City, Oklahoma 343 1,413
Philadelphia, Pennsylvania-New Jersey-Delaware-Maryland—Wilmington Division 212 1,430
Pittsburgh, Pennsylvania 292 1,878
Port St. Lucie-Fort Pierce, Florida 146 1,380
Providence-New Bedford-Fall River, Rhode Island-Massachusetts 168 1,390
Raleigh-Cary, North Carolina 335 1,852
Richmond, Virginia 499 2,177
Rochester, New York 188 1,522

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Commentary for definition of emerging communities (ECs).

*This MSA was formerly named Bradenton-Sarasota-Venice, Florida, but the counties delineating the metropolitan statistical area have not changed.

Table 3. Reported number of persons living with diagnosed HIV infection non-stage 3 (AIDS), infection ever classified as stage 3 (AIDS), and total, by area of residence, as of December 2020—United States and dependent areas for the Ryan White HIV/AIDS Program
HIV infection non-stage 3 (AIDS) HIV infection ever classified as stage 3 (AIDS) Total
Area of residence No. No. No.
Alabama 8,378 5,887 14,265
Alaska 362 398 760
Arizona 9,210 7,177 16,387
Arkansas 3,398 2,696 6,094
California 64,139 74,198 138,337
Colorado 7,290 5,493 12,783
Connecticut 4,083 6,571 10,654
Delaware 1,336 1,951 3,287
District of Columbia 6,790 8,287 15,077
Florida 56,520 59,350 115,870
Georgia 26,589 26,208 52,797
Hawaii 1,165 1,376 2,541
Idaho 498 477 975
Illinois 19,435 18,729 38,164
Indiana 6,064 5,593 11,657
Iowa 1,236 1,326 2,562
Kansas 1,715 1,734 3,449
Kentucky 3,987 3,511 7,498
Louisiana 11,444 11,144 22,588
Maine 630 665 1,295
Maryland 15,499 17,206 32,705
Massachusetts 9,419 11,158 20,577
Michigan 9,092 8,572 17,664
Minnesota 4,748 3,838 8,586
Mississippi 5,479 4,987 10,466
Missouri 6,817 6,632 13,449
Montana 245 259 504
Nebraska 1,084 1,079 2,163
Nevada 5,217 4,315 9,532
New Hampshire 639 612 1,251
New Jersey 18,458 18,868 37,326
New Mexico 1,607 1,699 3,306
New York 53,207 72,506 125,713
North Carolina 18,332 12,931 31,263
North Dakota 247 173 420
Ohio 12,620 10,545 23,165
Oklahoma 3,547 2,863 6,410
Oregon 2,909 3,535 6,444
Pennsylvania 16,379 19,122 35,501
Rhode Island 1,132 1,413 2,545
South Carolina 8,619 9,284 17,903
South Dakota 374 276 650
Tennessee 10,008 8,725 18,733
Texas 48,205 46,767 94,972
Utah 1,646 1,515 3,161
Vermont 229 282 511
Virginia 13,130 11,102 24,232
Washington 6,538 6,831 13,369
West Virginia 1,005 956 1,961
Wisconsin 3,332 2,899 6,231
Wyoming 173 165 338
American Samoa 0 1 1
Federated States of Micronesia* 0 0 0
Guam 70 44 114
Marshall Islands* 0 1 1
Northern Mariana Islands 5 10 15
Palau 5 4 9
Puerto Rico 8,420 9,709 18,129
U.S. Virgin Islands 268 349 617

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. The number of cases shown in the Total column was used by the Health Resources and Services Administration in FY 2022 funding calculations.

*See Technical Notes regarding data reported for these jurisdictions.

Table 4. Reported number of persons living with diagnosed HIV infection non-stage 3 (AIDS), infection ever classified as stage 3 (AIDS), and total, by area of residence, as of December 2020—eligible metropolitan areas and transitional grant areas for the Ryan White HIV/AIDS Program
HIV infection non-stage 3 (AIDS) HIV infection ever classified as stage 3 (AIDS) Total
Area of residence No. No. No.
Eligible metropolitan areas (EMAs)
Atlanta-Sandy Springs-Marietta, Georgia 17,515 17,715 35,230
Baltimore, Maryland 8,384 9,591 17,975
Boston-Brockton-Nashua, Massachusetts-New Hampshire 8,454 10,003 18,457
Chicago, Illinois 16,641 15,884 32,525
Dallas, Texas 11,813 11,497 23,310
Detroit, Michigan 5,882 5,703 11,585
Fort Lauderdale, Florida 9,464 9,457 18,921
Houston, Texas 14,808 15,184 29,992
Los Angeles-Long Beach, California 25,433 28,279 53,712
Miami, Florida 16,422 14,675 31,097
Nassau-Suffolk, New York 2,753 3,542 6,295
New Haven-Bridgeport-Danbury-Waterbury, Connecticut 2,327 3,825 6,152
New Orleans, Louisiana 4,460 4,602 9,062
New York, New York 43,123 59,818 102,941
Newark, New Jersey 6,872 6,894 13,766
Orlando, Florida 6,777 6,253 13,030
Philadelphia, Pennsylvania-New Jersey 12,111 13,638 25,749
Phoenix-Mesa, Arizona 7,173 5,370 12,543
San Diego, California 6,867 7,410 14,277
San Francisco, California 7,308 10,357 17,665
San Juan-Bayamon, Puerto Rico 5,633 6,069 11,702
Tampa-St. Petersburg-Clearwater, Florida 6,040 6,634 12,674
Washington, DC-Maryland-Virginia-West Virginia 17,329 19,201 36,530
West Palm Beach-Boca Raton, Florida 3,564 4,913 8,477
Transitional grant areas (TGAs)
Austin-San Marcos, Texas 3,257 3,247 6,504
Baton Rouge, Louisiana 2,715 2,713 5,428
Bergen-Passaic, New Jersey 2,204 2,384 4,588
Charlotte-Gastonia-Concord, North Carolina-South Carolina 4,834 3,086 7,920
Cleveland-Lorain-Elyria, Ohio 3,146 2,689 5,835
Columbus, Ohio 3,453 2,568 6,021
Denver, Colorado 5,578 4,101 9,679
Fort Worth-Arlington, Texas 3,277 2,912 6,189
Hartford, Connecticut 1,372 2,177 3,549
Indianapolis, Indiana 3,004 2,719 5,723
Jacksonville, Florida 3,447 3,894 7,341
Jersey City, New Jersey 2,753 2,869 5,622
Kansas City, Missouri-Kansas 2,580 2,871 5,451
Las Vegas, Nevada-Arizona 4,670 3,839 8,509
Memphis, Tennessee-Mississippi-Arkansas 4,496 3,770 8,266
Middlesex-Somerset-Hunterdon, New Jersey 1,622 1,660 3,282
Minneapolis-St. Paul, Minnesota-Wisconsin 4,164 3,319 7,483
Nashville-Davidson-Murfreesboro, Tennessee 3,093 2,606 5,699
Norfolk-Virginia Beach-Newport News, Virginia 4,087 2,841 6,928
Oakland, California 3,744 5,060 8,804
Orange County, California 3,982 4,102 8,084
Portland-Vancouver, Oregon-Washington 2,451 2,768 5,219
Riverside-San Bernardino, California 5,194 5,459 10,653
Sacramento, California 2,178 2,148 4,326
St. Louis, Missouri-Illinois 4,089 3,683 7,772
San Antonio, Texas 3,719 3,429 7,148
San Jose, California 1,700 2,355 4,055
Seattle-Bellevue-Everett, Washington 4,452 4,563 9,015

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Commentary for definition of eligible metropolitan areas (EMAs) and transitional grant areas (TGAs).

The number of cases shown in the Total column was used by the Health Resources and Services Administration in FY 2022 funding calculations.

Table 5. Reported number of persons living with diagnosed HIV infection non-stage 3 (AIDS), infection ever classified as stage 3 (AIDS), and total, by area of residence, as of December 2020—emerging communities for the Ryan White HIV/AIDS Program
HIV infection non-stage 3 (AIDS) HIV infection ever classified as stage 3 (AIDS) Total
Emerging communities (ECs) No. No. No.
Albany-Schenectady-Troy, New York 903 1,100 2,003
Augusta-Richmond County, Georgia-South Carolina 1,181 1,222 2,403
Bakersfield, California 1,200 1,253 2,453
Birmingham-Hoover, Alabama 2,584 1,675 4,259
Buffalo-Niagara Falls, New York 1,295 1,202 2,497
Charleston – North Charleston, South Carolina 1,428 1,371 2,799
Cincinnati-Middletown, Ohio-Kentucky-Indiana 2,510 2,207 4,717
Columbia, South Carolina 2,144 2,476 4,620
Jackson, Mississippi 1,902 1,752 3,654
Lakeland, Florida 995 1,202 2,197
Louisville, Kentucky-Indiana 2,163 1,756 3,919
Milwaukee-Waukesha-West Allis, Wisconsin 1,843 1,606 3,449
North Port-Bradenton-Sarasota, Florida* 854 1,059 1,913
Oklahoma City, Oklahoma 1,763 1,413 3,176
Philadelphia, Pennsylvania-New Jersey-Delaware-Maryland—Wilmington Division 976 1,430 2,406
Pittsburgh, Pennsylvania 1,746 1,878 3,624
Port St. Lucie-Fort Pierce, Florida 703 1,380 2,083
Providence-New Bedford-Fall River, Rhode Island-Massachusetts 1,091 1,390 2,481
Raleigh-Cary, North Carolina 2,220 1,852 4,072
Richmond, Virginia 2,704 2,177 4,881
Rochester, New York 1,251 1,522 2,773

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Commentary for definition of emerging communities (ECs).
The number of cases shown in the Total column was used by the Health Resources and Services Administration in FY 2022 funding calculations.

*This MSA was formerly named Bradenton-Sarasota-Venice, Florida, but the counties delineating the metropolitan statistical area have not changed.